Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
200 participants
OBSERVATIONAL
2014-01-31
2030-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this registry is to collect prospectively and systematically clinical research data from patients undergoing PMVR with the MitraClip® system. This registry is an open-end observational study to assess the characteristics and outcomes patients with severe mitral regurgitation undergoing PMVR.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ACCESS-Europe A Two-Phase Observational Study of the MitraClip® System in Europe
NCT01288976
MitraClip® After Surgical Mitral Valve Repair
NCT02853955
Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients With Severe Primary Mitral Regurgitation Eligible for High-risk Surgery
NCT03271762
A Multicenter, Randomized, Controlled Study to Assess Mitral vAlve reconsTrucTion for advancEd Insufficiency of Functional or iscHemic ORigiN
NCT02371512
Belgian Mitraclip Registry
NCT02506387
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* percutaneous mitral valve repair (PMVR) with the MitraClip® system
Exclusion Criteria
* Patients considered by the heart team to be unlikely to receive meaningful or durable clinical benefit from the procedure
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Klinik für Kardiologie, Pneumologie und Angiologie
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Klinik für Kardiologie, Pneumologie und Angiologie
Director Division of Cardiology, Pulmonary Disease and Vascular Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Malte Kelm, MD
Role: PRINCIPAL_INVESTIGATOR
Division of Cardiology, Pulmonary Disease and Vascular Medicine
Malte Kelm, MD
Role: STUDY_CHAIR
Division of Cardiology, Pulmonary Disease and Vascular Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Heinrich Heine University Div. of Cardiology, Pulmonary Disease and Vasculae Medicine
Düsseldorf, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Malte Kelm, MD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Malte Kelm, MD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Herbrand T, Eschenhagen S, Zeus T, Kehmeier E, Hellhammer K, Veulemans V, Kelm M, Balzer J. Acute reverse annular remodeling during MitraClip(R) therapy predicts improved clinical outcome in heart failure patients: a 3D echocardiography study. Eur J Med Res. 2017 Sep 20;22(1):33. doi: 10.1186/s40001-017-0273-x.
Rammos C, Zeus T, Balzer J, Veulemans V, Hellhammer K, Niebel S, Kelm M, Rassaf T. Left Atrial and Left Ventricular Function and Remodeling Following Percutaneous Mitral Valve Repair. J Heart Valve Dis. 2016 May;25(3):309-319.
Hellhammer K, Zeus T, Balzer J, van Hall S, Rammos C, Wagstaff R, Kelm M, Rassaf T. Safety and efficacy of percutaneous mitral valve repair using the MitraClip(R) system in patients with diabetes mellitus. PLoS One. 2014 Nov 6;9(11):e111178. doi: 10.1371/journal.pone.0111178. eCollection 2014.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MitraClip® Registry
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.